CHEK1 and non-small cell lung carcinoma: Upon comparing SCLC (n = 21) with NSCLC (n = 341), drugs targeting Chk1, Aurora, Wee1, and PI3K-Akt were identified as candidates for SCLC sensitivity (Figure 5C).